Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine. [PDF]
Zhao LP +15 more
europepmc +1 more source
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial. [PDF]
Mohty M +19 more
europepmc +1 more source
L'implantation et l'extension du choléra en Afrique noire : 1970-1980 [PDF]
Carme, B. +4 more
core
A longitudinal study of right ventricular function of patients with multiple myeloma treated with carfilzomib. [PDF]
Basin S +10 more
europepmc +1 more source
Predicting the toxicity-efficacy ratio of venetoclax in real-world patients. [PDF]
Osanno L +16 more
europepmc +1 more source
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort. [PDF]
Cortes J +15 more
europepmc +1 more source
Correction to: VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease. [PDF]
Mezalek ZT +10 more
europepmc +1 more source
Comparative safety of drug therapies used in hemophilia A and B in Canada: a multi-center, retrospective study. [PDF]
Olasupo OO +15 more
europepmc +1 more source
La medecine nucleaire - Etat actuel - Situation en France
Swiniarski, R. De
core +1 more source

